Dolby Laboratories, Inc. (DLB) Cash flow
Market cap
$5.1B
P/E ratio
20.2x
| 2010/09 | 2011/09 | 2012/09 | 2013/09 | 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | 2025/09 | |
| Stock-based compensation | 28 | 44 | 48 | 64 | 66 | 67 | 67 | 65 | 71 | 77 | 87 | 100 | 115 | 118 | 120 | 129 |
| Cash from operations | 327 | 404 | 390 | 275 | 362 | 309 | 357 | 371 | 352 | 328 | 344 | 448 | 319 | 367 | 327 | 472 |
| Capital expenditures | -37 | -47 | -167 | -27 | -79 | -158 | -101 | -100 | -73 | -96 | -66 | -54 | -48 | -30 | -30 | -36 |
| Cash from investing | -44 | -237 | -195 | 177 | -205 | -204 | -282 | -162 | 78 | -56 | 134 | -45 | -296 | 54 | -286 | -11 |
| Payments for dividends | - | - | - | 408 | - | 41 | 48 | 57 | 66 | 77 | - | - | - | - | - | - |
| Repurchases of common stock | 241 | 192 | 268 | 82 | 56 | 107 | 101 | 100 | 150 | 341 | 174 | 246 | 530 | 149 | 160 | 125 |
| Repayments of term debt | 8 | - | 1 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | -185 | -162 | -254 | -488 | -41 | -139 | -89 | -100 | -134 | -385 | -208 | -253 | -611 | -237 | -288 | -247 |
| Free cash flow | ||||||||||||||||
| FCF margin (%) |